Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

228.25
-0.4300-0.19%
Post-market: 228.270.0200+0.01%16:20 EDT
Volume:5.72M
Turnover:1.31B
Market Cap:403.22B
PE:108.68
High:229.86
Open:228.99
Low:227.25
Close:228.68
52wk High:244.81
52wk Low:163.81
Shares:1.77B
Float Shares:1.76B
Volume Ratio:1.19
T/O Rate:0.32%
Dividend:6.47
Dividend Rate:2.83%
EPS(TTM):2.10
EPS(LYR):2.40
ROE:112.85%
ROA:8.87%
PB:-2203.37
PE(LYR):95.27

Loading ...

Feb 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2025

Major Issues Report

Form 8-K - Current report
Feb 05, 2025

Major Issues Report

Form 8-K - Current report
Jan 31, 2025

Major Issues Report

Form 8-K - Current report
Jan 10, 2025

Major Issues Report

Form 8-K - Current report
Jan 06, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 04, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 04, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2024

Major Issues Report

Form 8-K - Current report